Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00592379 versus sildenafil for erectile function in men with erectile dysfunction
2005-004648-30Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PF-000592379 in erectile dysfunction (ED) (4 arms), sponsored by Pfizer. Primary endpoint: Total duration of erections ≥60% rigidity at the base of the penis during visual sexual stimulation. Started Nov 2005; status: completed.
02
Drugs
PF-000592379
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2005-004648-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004648-30.